Titlebook: Intraoperative Radiotherapy; Clinical Experiences Felipe Angel Calvo (Director and Consultant),Luthe Textbook 1992 Springer-Verlag Berlin H

CAB

Head and Neck Cancer,pital of Indiana (. et al. 1989). IORT can be introduced in the multidisciplinary management of head and neck cancer as a boosting modality in areas of residual disease or close surgical margins in patients with locally advanced tumor, in an effort to promote local tumor control. The potential advan

含铁

Lung Cancer,programs are needed to increase both median survival time and overall survival rates (RICHARDS and SCARANTINO 1985). Stage III nonsmall cell lung cancer is considered a disease stage that will have a marginal benefit from surgery. In most cases residual disease will be left in the mediastinum and/or

连接

Pancreatic Cancer,ORT: the tumor is accurately defined at the time of surgery and the surrounding normal tissues can be mobilized to expose the tumor to the electron beam. These positive aspects have led to high expectations regarding the results of intensive locoregional treatment including IORT. On the other hand,

GRE

Colorectal Cancer,esults of preoperative and postoperative radiotherapy trials, with or without chemotherapy, are consistent with high local tumor control rates (. et al. 1983; . and . 1988). Phase III trials have established the value of combined modality treatment in rectal cancer (Gastrointestinal Tumor Study Grou

forthy

公司

缓解

安装

者变

,Ewing’s Sarcoma, component of the treatment of the primary lesion. The reported rates of local control attributed to radiation therapy vary widely (. et al. 1989). Tumor volume and the site of the primary tumor have been related to major differences in local tumor control. Thus isolated local recurrences have been

angina-pectoris